Rat Tissue Array: Brain, heart, kidney, liver, lung, muscle, spleen and stomach, each tissue from 10 female and 10 male, respectively from BioChain
| Products | Rat Tissue Array: Brain, heart, kidney, liver, lung, muscle, spleen and stomach, each tissue from 10 female and 10 male, respectively from BioChain |
| Company | BioChain |
| Item | Rat Tissue Array: Brain, heart, kidney, liver, lung, muscle, spleen and stomach, each tissue from 10 female and 10 male, respectively |
| Price | $619.00 |
| Description | Rat adult normal paraffin tissue array is designed for rapidly screening genes or proteins of interest in extensive panels of different types of tissues. Rat brain, heart, kidney, liver, lung, muscle, spleen and stomach tissues are arrayed on positively charged glass slide. Each tissue is from 10 female and 10 male, respectively |
| Info | BioChain BioChain Institute, Inc.
3517 Breakwater Avenue
Hayward, CA 94545 USA
Call BioChain to buy products (US and Canada only; other locations use numbers below)
 1-510-342-5324 |
Customer Service: 510.783.8588 Fax Number: 510.783.5386 Web Site: http://www.biochain.com |
NOTE: Price information is approximate list price and actual prices may vary.
Related biology products :1.
MaxArray Tissue Array (Animal - Rabbit) from Invitrogen2.
Mitochondria Isolation Kit for Tissue and Cultured Cells from BioChain3.
Normal Rabbit Tissues from CHEMICON4.
Normal Rabbit Tissues from CHEMICON5.
Vibratome 800 - McIllwain Tissue Chopper - 230V CE from myNeuroLab.com6.
Vibratome 800 - McIllwain Tissue Chopper from myNeuroLab.com7.
Anti-Rat HRP-AEC Cell & Tissue Staining Kit from R&D Systems8.
Anti-Rat HRP-DAB Cell & Tissue Staining Kit from R&D Systems9.
Tissue Trans-glutaminase-directed IgA EIA Kit from Alpco Diagnostics10.
Mouse Paraffin Digestive Tissue Microarray from Zyagen Laboratories11.
Mouse Frozen Reproductive Tissue Microarray from Zyagen Laboratories
Uniform 13C, 15N, Labeling of Peptides and Proteins new from rPeptide, LLC
Macrocarriers, for PDS-1000 He and Hepta systems, 500 from Bio-Rad
...[pTyr 209/ pSer 211 ] affinity isolated antibody ...ate buffered saline (without Mg 2+ and Ca 2+ ), p...and 0.05% sodium azide. a synthetic phosphorylated... contains tyrosine 207 and serine 209 (correspondi...
Max-Power 2000V Power Supply from Major Science
Biology Products:(Date:11/24/2009)..., Iceland, November 24 d...ed the approval of all of its,"first day" motions ...elaware,(the "Bankruptcy Court"). deCODE last week...er 11 of the United States Bankruptcy Code with th...y the Bankruptcy Court allow the company to contin...
(Date:11/24/2009).... 24 NeurogesX, Inc. (Na... on developing and commercializing novel pain mana...onno, President and Chief Executive Officer, is sc...y Health Care Conference, to be held December 1-2,...w York. ,, Mr. DiTonno and Stephen Ghiglieri, ...
(Date:11/24/2009)...re/ -- Blue Marble Energy Corp. announced today th...uthority (OPDA) were recently awarded $2 million b...tion Board (CERB) in a private/public partnership ...al biorefinery in Lincoln County, WA. ,, "Thi...ent of our biorefinery and bring over 70 green job...
(Date:11/24/2009)...point has been met for patients with advanced-stag...EC CITY, Nov. 24 /PRNewswire-FirstCall/ - AEterna ...pany"), a global biopharmaceutical company focused...d positive efficacy data from a Phase 2 study with...8 (formerly AN-152), in patients with advanced or ...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4